# US 2008/0076775 A1 · 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0076775 A1
- Document ID: US20080076775A1
- Status: Published application
- Kind: A1
- Application number: 11/867,366
- Filed: 2007-10-04
- Published: 2008-03-27
- Earliest claimed: 2002-04-03
- Assignees: Sanofi-Aventis
- Inventors: Jacques FROISSANT; Benoit MARABOUT; Frank MARGUET; Frederic PUECH
- Web page: https://patentgrep.com/patent/US20080076775A1

## CPC

- C07D 209/42: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/04: Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A61P 9/08: Vasodilators for multiple indications
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 13/12: of the kidneys
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/04: Antipruritics
- A61P 17/06: Antipsoriatics
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/02: for peripheral neuropathies
- A61P 25/16: Anti-Parkinson drugs
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 35/00: Antineoplastic agents
- A61P 37/02: Immunomodulators
- C07D 487/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention discloses and claims therapeutic uses of compounds of general formula (I) Wherein X, R1, R2 and R3 are as described herein. The invention further discloses processes for preparing them, and novel intermediates therefor.

## Claims

### Claim 1

A compound of the formula (III):
in which
X represents a hydrogen or halogen atom,
R1 represents a hydrogen atom or a (C1-C4)alkyl group,
R′ and R″, each independently of one another, represent a (C1-C4)alkyl group.

### Claim 2

A compound of the formula (IV):
in which
X represents a hydrogen or halogen atom,
R1 represents a hydrogen atom or a (C1-C4)alkyl group,
R′ represents a (C1-C4)alkyl group,
R2 and R3, each independently of one another, represent a hydrogen atom or a (C1-C4)alkyl group, or else R2 and R3, together with the nitrogen atom bearing them, form a pyrrolidinyl, piperidinyl, morpholinyl or 4-(C1-C4)alkylpiperazinyl group.

### Claim 3

A method of treating Alzheimer's disease in a patient comprising administering to said patient an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof:
in which
X represents a hydrogen or halogen atom,
R1 represents a hydrogen atom or a (C1-C4)alkyl group,
R2 and R3 each independently of one another represent a hydrogen atom or a (C1-C4)alkyl group, or else R2 and R3, together with the nitrogen atom bearing them, form a pyrrolidinyl, piperidinyl, morpholinyl or 4-(C1-C4)alkylpiperazinyl group, and
Het represents a heteroaromatic group of pyridinyl, quinolinyl, isoquinolinyl, pyrimidinyl, pyrazinyl or pyridazinyl type which may carry one or more halogen atoms and/or one or more (C1-C4) alkyl and/or (C1-C4)alkoxy groups.

### Claim 4 (depends on 3)

The method according to claim 3, wherein X represents a halogen atom.

### Claim 5 (depends on 3)

The method according to claim 3, wherein R1 represents a (C1-C4)alkyl.

### Claim 6 (depends on 3)

The method according to claim 3, wherein R2 and R3, each independently of one another, represent a (C1-C4)alkyl group or else R2 and R3, together with the nitrogen atom bearing them, form a pyrrolidinyl or 4-(C1-C4)alkylpiperazinyl group.

### Claim 7 (depends on 3)

The method according to claim 3, wherein Het represents a heteroaromatic group of pyridinyl type which may carry one or more halogen atoms and/or one or more (C1-C4)alkyl and/or (C1-C4)alkoxy groups.

### Claim 8 (depends on 3)

The method according to claim 3, wherein X represents a chlorine atom and R1 represents a methyl group.
